Serum levels of some biomarkers associated with metabolic syndrome, adipokines such as adiponectin, and biomarkers of endothelial cell activation and inflammation may appear to be useful in predicting cardiovascular risk in patients with RA (72). This evidence concerns the gene ADIPOQ and metabolic syndrome.